Healwell AI Engages Investors with Aggressive Conference Schedule

Healwell AI Inc. announces a targeted March 2026 investor relations campaign, featuring presentations at three major conferences led by President Dr. Alexander Dobranowski.

Healwell AI Inc., a Canadian firm specializing in artificial intelligence for early disease detection, is launching a targeted investor relations campaign throughout March 2026. The company has scheduled appearances at three major financial conferences, aiming to showcase its technology platform and engage directly with the institutional investment community. Company President Dr. Alexander Dobranowski will lead the presentations and discussions.

Strategic Investor Outreach

The initiative underscores Healwell AI's active pursuit of dialogue with capital markets. The series of presentations is designed to highlight recent technological advancements and strategic growth plans. The ultimate impact on the company's share price will depend on how effectively it communicates its progress in platform development and market penetration.

The core of the campaign involves not only public presentations but also numerous private one-on-one meetings with investors. These sessions will focus on the latest developments in Healwell's AI platform, which is built to assist physicians in identifying patient disease risks earlier.

A Packed Calendar of Events

The company's roadshow spans four weeks, commencing with the 46th Annual TD Cowen Health Care Conference in Boston, held from March 2 to 4. Dr. Dobranowski is slated to present the company's strategic direction to attending investors on March 3.

Concurrently, Healwell AI will participate in the 29th Annual Scotiabank TMT Conference in Toronto. Here, Dr. Dobranowski will host a fireside chat on the morning of March 4, fielding questions on business trajectory and core technology.

The final engagement is the 38th Annual ROTH Investor Conference in Dana Point, California, running from March 22 to 24. On March 23, Dr. Dobranowski will join a panel discussion focused on technologies for healthy aging—a theme that aligns directly with Healwell AI's foundational mission of early diagnosis.